欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/4806/001
药品名称
Cetirmar 5 mg tablets
活性成分
levocetirizine dihydrochloride 5.0 mg
剂型
Film-coated tablet
上市许可持有人
Synthon BV
参考成员国 - 产品名称
Netherlands (NL)
Cetirmar
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
PL 14048/0040 - 0013
Germany (DE)
Cetirmar 5 mg Tabletten
Italy (IT)
许可日期
2009/07/30
最近更新日期
2023/11/15
药物ATC编码
R06AE09 levocetirizine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
M1_3_1_01_LCZ_dhc_tab_003_12_Core
Date of last change:2024/09/06
Final Labelling
|
M1_3_1_02_LCZ_dhc_tab_003_04_Core
Date of last change:2024/09/06
Final PL
|
M1_3_1_03_LCZ_dhc_tab_003_11_Core
Date of last change:2024/09/06
PubAR
|
PAR_4806_Cetirmar_2Mar2023
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase